The effects of platelet-rich plasma in the treatment of large-joint osteoarthritis: A systematic review

David C. Tietze, Kyle Geissler, James Borchers

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Context: Osteoarthritis (OA) is a common and costly condition with both operative and nonoperative treatments available. Platelet-rich plasma (PRP) is emerging as a treatment option for a variety of musculoskeletal pathologies, including OA. Objective: To evaluate the effectiveness of intra-articular PRP injection in the treatment of large-joint OA. Data Sources: PubMed, Web of Knowledge, Scopus, and the Cochrane Database were searched. The references of all articles that met the inclusion criteria were manually searched for additional articles. Study Selection: English studies that enrolled human participants were included, with level of evidence I to IV. Results: Thirteen articles met the inclusion criteria: 12 focused on knee OA, and 1 on hip OA. All studies showed statistically significant improvement in patient outcome scores with PRP. Platelet-rich plasma has a statistically significant benefit in knee OA when compared with hyaluronic acid. The benefit from PRP appears to last between 6 and 12 months. Conclusion: Platelet-rich plasma may be an effective treatment for knee OA. However, because of the low level of evidence, small sample sizes, and wide variability in treatment, no definitive recommendations can be made at this time.

Original languageEnglish (US)
Pages (from-to)27-37
Number of pages11
JournalPhysician and Sportsmedicine
Volume42
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Platelet-Rich Plasma
Osteoarthritis
Joints
Knee Osteoarthritis
Therapeutics
Hip Osteoarthritis
Information Storage and Retrieval
Hyaluronic Acid
PubMed
Sample Size
Databases
Pathology
Injections

Keywords

  • Cartilage
  • Chondropathy
  • Hip osteoarthritis
  • Intra-articular injection
  • Knee osteoarthritis
  • Platelet-rich plasma

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

The effects of platelet-rich plasma in the treatment of large-joint osteoarthritis : A systematic review. / Tietze, David C.; Geissler, Kyle; Borchers, James.

In: Physician and Sportsmedicine, Vol. 42, No. 2, 01.01.2014, p. 27-37.

Research output: Contribution to journalArticle

@article{93458fe584504f7bb875b36360a31056,
title = "The effects of platelet-rich plasma in the treatment of large-joint osteoarthritis: A systematic review",
abstract = "Context: Osteoarthritis (OA) is a common and costly condition with both operative and nonoperative treatments available. Platelet-rich plasma (PRP) is emerging as a treatment option for a variety of musculoskeletal pathologies, including OA. Objective: To evaluate the effectiveness of intra-articular PRP injection in the treatment of large-joint OA. Data Sources: PubMed, Web of Knowledge, Scopus, and the Cochrane Database were searched. The references of all articles that met the inclusion criteria were manually searched for additional articles. Study Selection: English studies that enrolled human participants were included, with level of evidence I to IV. Results: Thirteen articles met the inclusion criteria: 12 focused on knee OA, and 1 on hip OA. All studies showed statistically significant improvement in patient outcome scores with PRP. Platelet-rich plasma has a statistically significant benefit in knee OA when compared with hyaluronic acid. The benefit from PRP appears to last between 6 and 12 months. Conclusion: Platelet-rich plasma may be an effective treatment for knee OA. However, because of the low level of evidence, small sample sizes, and wide variability in treatment, no definitive recommendations can be made at this time.",
keywords = "Cartilage, Chondropathy, Hip osteoarthritis, Intra-articular injection, Knee osteoarthritis, Platelet-rich plasma",
author = "Tietze, {David C.} and Kyle Geissler and James Borchers",
year = "2014",
month = "1",
day = "1",
doi = "10.3810/psm.2014.05.2055",
language = "English (US)",
volume = "42",
pages = "27--37",
journal = "Physician and Sportsmedicine",
issn = "0091-3847",
publisher = "JTE Multimedia",
number = "2",

}

TY - JOUR

T1 - The effects of platelet-rich plasma in the treatment of large-joint osteoarthritis

T2 - A systematic review

AU - Tietze, David C.

AU - Geissler, Kyle

AU - Borchers, James

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Context: Osteoarthritis (OA) is a common and costly condition with both operative and nonoperative treatments available. Platelet-rich plasma (PRP) is emerging as a treatment option for a variety of musculoskeletal pathologies, including OA. Objective: To evaluate the effectiveness of intra-articular PRP injection in the treatment of large-joint OA. Data Sources: PubMed, Web of Knowledge, Scopus, and the Cochrane Database were searched. The references of all articles that met the inclusion criteria were manually searched for additional articles. Study Selection: English studies that enrolled human participants were included, with level of evidence I to IV. Results: Thirteen articles met the inclusion criteria: 12 focused on knee OA, and 1 on hip OA. All studies showed statistically significant improvement in patient outcome scores with PRP. Platelet-rich plasma has a statistically significant benefit in knee OA when compared with hyaluronic acid. The benefit from PRP appears to last between 6 and 12 months. Conclusion: Platelet-rich plasma may be an effective treatment for knee OA. However, because of the low level of evidence, small sample sizes, and wide variability in treatment, no definitive recommendations can be made at this time.

AB - Context: Osteoarthritis (OA) is a common and costly condition with both operative and nonoperative treatments available. Platelet-rich plasma (PRP) is emerging as a treatment option for a variety of musculoskeletal pathologies, including OA. Objective: To evaluate the effectiveness of intra-articular PRP injection in the treatment of large-joint OA. Data Sources: PubMed, Web of Knowledge, Scopus, and the Cochrane Database were searched. The references of all articles that met the inclusion criteria were manually searched for additional articles. Study Selection: English studies that enrolled human participants were included, with level of evidence I to IV. Results: Thirteen articles met the inclusion criteria: 12 focused on knee OA, and 1 on hip OA. All studies showed statistically significant improvement in patient outcome scores with PRP. Platelet-rich plasma has a statistically significant benefit in knee OA when compared with hyaluronic acid. The benefit from PRP appears to last between 6 and 12 months. Conclusion: Platelet-rich plasma may be an effective treatment for knee OA. However, because of the low level of evidence, small sample sizes, and wide variability in treatment, no definitive recommendations can be made at this time.

KW - Cartilage

KW - Chondropathy

KW - Hip osteoarthritis

KW - Intra-articular injection

KW - Knee osteoarthritis

KW - Platelet-rich plasma

UR - http://www.scopus.com/inward/record.url?scp=84908342652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908342652&partnerID=8YFLogxK

U2 - 10.3810/psm.2014.05.2055

DO - 10.3810/psm.2014.05.2055

M3 - Article

C2 - 24875970

AN - SCOPUS:84908342652

VL - 42

SP - 27

EP - 37

JO - Physician and Sportsmedicine

JF - Physician and Sportsmedicine

SN - 0091-3847

IS - 2

ER -